NEWS: Bournemouth, UK – 27th April 2015: Solentim will be exhibiting and promoting key presentations at both IBC Annual Cell Line Development & Engineering Conferences taking place next month at the Parc 55 Hilton, San Francisco (US), May 18-20 and then at the Grand Hyatt, Shanghai (China), May 19-22. Both meetings are high profile international forums for scientists in the cell line development community.
Solentim invite customers and delegates to attend the following scientific agenda presentations which feature use of the Cell Metric™ technology:
San Francisco, CA – Tuesday May 19, 2.30pm:
“Assessment of Clonality for Production Cell Lines via High-Resolution Imaging”
- Melisa Carpio, Senior Research Associate II, Cell Engineering, Takeda California
Shanghai, China – Wednesday May 20, 11.40am:
“Efficient Screening Strategies to Select Clones & Reduce Timelines”
- Chaomei He, Principal Scientist, Momenta Pharmaceuticals, USA
At each IBC event, Solentim will feature its leading Cell Metric™ cell documentation system for proof of clonality of manufacturing cell lines. The Solentim team extend a warm welcome to booth visitors to learn more about how the Cell Metric™ represents a major step-change in image quality for clonality and how the clone screening and selection workflow can be redefined.
“To have scientists from a number of the world’s most recognised biopharma companies presenting data using Cell Metric™ at major conferences on opposite sides of the world is very gratifying”, commented Dr Ian Taylor, Sales & Marketing Director. He added, “It is further endorsement for the maturity, quality and proven performance of our platform in this key application for stable cell line clonality verification and confluence measurements.”
For more information, please come along to our booths in San Francisco and Shanghai or alternatively visit the website - www.solentim.com
------- ENDS -------
Commercial cell line development for biopharmaceutical production is a high value process which is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of innovative tools to shorten steps in the upstream cell line development workflow. The Cell Metric™ product range consists of bio-analytical imaging stations for rapid clone screening and documented proof of monoclonality for the FDA and other regulatory bodies. To find more information visit www.solentim.com
Dr Ian Taylor
E: [email protected]